Zealand Pharma As Stock Current Ratio
Zealand Pharma AS fundamentals help investors to digest information that contributes to Zealand Pharma's financial success or failures. It also enables traders to predict the movement of Zealand Stock. The fundamental analysis module provides a way to measure Zealand Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zealand Pharma stock.
Zealand |
Zealand Pharma AS Company Current Ratio Analysis
Zealand Pharma's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Zealand Pharma Current Ratio | 4.79 X |
Most of Zealand Pharma's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zealand Pharma AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Zealand Pharma AS has a Current Ratio of 4.79 times. This is 64.6% higher than that of the Biotechnology sector and 31.57% lower than that of the Health Care industry. The current ratio for all United States stocks is 121.76% lower than that of the firm.
Zealand Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zealand Pharma's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zealand Pharma could also be used in its relative valuation, which is a method of valuing Zealand Pharma by comparing valuation metrics of similar companies.Zealand Pharma is currently under evaluation in current ratio category among its peers.
Zealand Fundamentals
| Return On Equity | -1.15 | |||
| Return On Asset | -0.38 | |||
| Operating Margin | (3.28) % | |||
| Current Valuation | 1.32 B | |||
| Shares Outstanding | 46.12 M | |||
| Shares Owned By Institutions | 1.74 % | |||
| Number Of Shares Shorted | 75.47 K | |||
| Price To Earning | 10.49 X | |||
| Price To Book | 9.54 X | |||
| Price To Sales | 2.77 X | |||
| Revenue | 292.57 M | |||
| Gross Profit | 173.75 M | |||
| EBITDA | (982.6 M) | |||
| Net Income | (1.02 B) | |||
| Cash And Equivalents | 1.12 B | |||
| Cash Per Share | 25.99 X | |||
| Total Debt | 647.91 M | |||
| Debt To Equity | 1.11 % | |||
| Current Ratio | 4.79 X | |||
| Book Value Per Share | 10.91 X | |||
| Cash Flow From Operations | (1.21 B) | |||
| Short Ratio | 37.96 X | |||
| Earnings Per Share | (3.26) X | |||
| Target Price | 240.78 | |||
| Number Of Employees | 237 | |||
| Beta | 1.34 | |||
| Market Capitalization | 814.14 M | |||
| Total Asset | 2.07 B | |||
| Net Asset | 2.07 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Zealand Stock
If you are still planning to invest in Zealand Pharma AS check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zealand Pharma's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |